10:45-11:15 |
The role of CrkII in bone metabolism 김낙성(전남의대 약리학교실) |
|
11:15-11:45 |
Bone-targeted delivery of cell-penetrating-RUNX2 fusion protein in an osteoporosis model 황석연(서울대 화학생물공학부) |
|
11:45-12:15 |
Fracture risk linked to anti-diabetic and anti-hypertensive drugs: multicenter database evidence 공성혜(서울의대) |
16:45-17:15 |
Evidence-based guideline for the management of osteoporosis in men 박소영(경희의대) |
|
17:15-17:45 |
European consensus statement on the management of osteoporosis in chronic kidney disease stages G4-G5D 홍아람(전남의대) |
|
17:45-18:15 |
Global guidance for the management of tumor-induced osteomalacia 이승현(연세원주의대) |
14:00-14:30 |
Reinforcing the differentiation of oxidative muscle fibers by RORα-mediated upregulation of TFAM 이미옥(서울대 약학과) |
|
14:30-15:00 |
Mitochondrial metabolic reprogramming to mitigate sarcopenia 강종순(성균관의대 분자세포생물학교실) |
15:00-15:30 |
Myosteatosis: clinical implications for sarcopenia 김홍규(울산의대 건강의학과) |